Anixa Biosciences (ANIX) Shares Outstanding (Entity) (2011 - 2026)
Anixa Biosciences (ANIX) reported Shares Outstanding (Entity) of 34.58 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 5.4% from 32.82 million a year earlier and up 2.0% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Shares Outstanding (Entity) (2011 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), Anixa Biosciences posted Shares Outstanding (Entity) of 33.01 million, up 2.5% from FY2024.
- Shares Outstanding (Entity) has a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- By fiscal year, Shares Outstanding (Entity) came in at 32.2 million in FY2024 (+3.4%), 31.15 million in FY2023 and 30.05 million in FY2021 (+23.9%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q2 2011.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.6% (fiscal Q2 2025) and 23.9% (fiscal Q4 2021) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 34.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 34.58 Mn |
| Apr 30, 2026 | 33.92 Mn |
| Oct 31, 2025 | 33.01 Mn |
| Jul 31, 2025 | 32.82 Mn |
| Apr 30, 2025 | 32.21 Mn |
| Jan 31, 2025 | 32.20 Mn |
| Oct 31, 2024 | 32.20 Mn |
| Jul 31, 2024 | 32.15 Mn |
| Apr 30, 2024 | 32.01 Mn |
| Jan 31, 2024 | 31.75 Mn |
| Oct 31, 2023 | 31.15 Mn |
| Jul 31, 2023 | 31.02 Mn |
| Apr 30, 2023 | 30.96 Mn |
| Jul 31, 2022 | 30.65 Mn |
| Oct 31, 2021 | 30.05 Mn |
| Jul 31, 2021 | 29.95 Mn |
| Apr 30, 2021 | 31.45 Mn |
| Jan 31, 2021 | 26.18 Mn |
| Oct 31, 2020 | 24.25 Mn |
| Jul 31, 2020 | 23.65 Mn |
API Access
Anixa Biosciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();